Opendata, web and dolomites

MYA

MYA, the innovative diagnostics platform for the full mapping of personal allergies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MYA project word cloud

Explore the words cloud of the MYA project. It provides you a very rough idea of what is the project "MYA" about.

days    pharmacies    diagnostic    inadequate    primary    alltox    collect       population    contact    immunoglobulin    selling    detect    centres    accessible    profile    quantitatively    plex    immune    serve    personalized    full    life    turn    saturated    society    healthcare    worldwide    time    extreme    international    costly    suffering    affordable    patient    allergen    run    saved    screening    personal    individuals    limited    specialists    patients    care    cumulative    chronic    public    ready    relieve    advice    incurred    map    detection    array    made    420    proper    ship    units    quality    allergens    efficiency    inhalant    mya    gets    caused    diagnosis    treatment    launch    reducing    price    ige    market    million    food    treatments    entails    allergy    website    scarcity    provision    self    conveniently    weeks    benefits    disease    agree    laboratories    network    risk    prescribe    500    either    allergies    created    report    150    revenues   

Project "MYA" data sheet

The following table provides information about the project.

Coordinator
ALLTOX S.R.L. 

Organization address
address: VIA SARDEGNA 38
city: MILANO
postcode: 20146
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.alltox.it/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLTOX S.R.L. IT (MILANO) coordinator 50˙000.00

Map

 Project objective

Allergies are chronic conditions caused by an extreme immune response to inhalant and food allergens that affect today 500 million (M) individuals worldwide and 150 M in Europe. International institutions all agree in the benefits that early allergy diagnosis and targeted treatment could bring to society. However, only 5% of the population gets a proper diagnosis, either due to limited awareness or scarcity of allergy specialists. Thus, patients try to self-manage their condition and non-specialists prescribe inadequate treatments. Therefore, the patient’s quality of life could be improved if allergy diagnosis were made accessible to the general public. Also, € 30 M/year would be saved in Europe by enhancing the efficiency of our healthcare system. In response, ALLTOX has created MYA (Map Your Allergies), a high quality, cost-effective test for allergy screening. Our 40-plex array-based technology will serve to quantitatively detect the patient’s immunoglobulin IgE, which are produced by the immune system upon contact with a particular allergen. The personal allergy profile can be obtained and thus, facilitate an adequate management. MYA will be offered to the general public at an affordable price through a network of pharmacies and primary care centres, who will collect the sample and ship it to our selected laboratories to run the analysis. In only 3 days, a full report and personalized advice will be conveniently available to the patient through our website, greatly reducing the current time-to-diagnosis (8 weeks). Our product entails a cost-effective diagnostic test that will facilitate detection of allergy risk and provision of adequate management to those patients suffering from this chronic disease. Also, the MYA test will help to relieve the costly impact incurred by allergies on our ready saturated healthcare system. In turn, MYA will provide ALLTOX estimated cumulative revenues of €40.2 M after selling 420 000 units within five years from market launch.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MYA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MYA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More